What is the ticker symbol for Abeona Therapeutics?

Abeona Therapeutics trades under the ticker ABEO on NASDAQ.

What sector does Abeona Therapeutics operate in?

Abeona Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ABEO in a portfolio?

PortView shows ABEO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Abeona Therapeutics (ABEO) Stock Analysis

NASDAQHealthcareBiotechnology

$5.96-0.42%

1-year price historyRange $4.17 – $7.46

52-week range$5.96

$4.00$7.65

What Abeona Therapeutics does

Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for treating recessive dystrophic epidermolysis bullosa. The company's pipeline also features several other promising therapies: ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A. ABO-201, intended for CLN3 disease. ABO-401, developed to treat cystic fibrosis. ABO-50X, aimed at various genetic eye disorders. Additionally, Abeona is advancing AAV-based gene therapy solutions through its proprietary AIM vector platform. The company, which was founded in 1974 and is headquartered in New York, New York, changed its name to Abeona Therapeutics Inc. in June 2015, having previously been known as PlasmaTech Biopharmaceuticals, Inc.

Key metrics

Market cap

$339.41M

P/E (TTM)

-5.46

EPS (TTM)

$-1.09

Beta

1.34

Dividend yield

0.00%

Revenue / share

$0.45

50-day avg

$6.40

200-day avg

$5.47

52-week high

$7.65

52-week low

$4.00

CEO

Vishwas Seshadri

ETFs linked to ABEO

Broad-market and Healthcare sector ETFs an investor holding Abeona Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ABEO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ABEO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Abeona Therapeutics?: Abeona Therapeutics trades under the ticker ABEO on NASDAQ.
Which exchange is ABEO listed on?: ABEO is listed on NASDAQ.
What sector does Abeona Therapeutics operate in?: Abeona Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ABEO in a portfolio?: PortView shows ABEO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.